Redeye recognizes that volatile sales over quarters are currently an issue for the share performance. We have revised our sales estimates downwards after a weaker-than-expected organic growth. We are, however, convinced that the company will bounce back and likely show healthy growth, at least from Q4 and into 2025e. Our view is based on the long-term transformation of acquisitions made and riding the smart city trend. We lower our Base case to SEK 28(29) per share.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Tagmaster Q2 - Organic growth volatility continues

© Modular Finance, source Nordic Press Releases